Table 1. Known genotoxic compounds identified with the DDR-Act-Fp reporter system amongst 1,280 pharmacologically compounds of the LOPAC library.
Fluorescence (% of pos. control) | ID | Compound name | Mode of action |
---|---|---|---|
100 | Pos. control | Etoposide | Topoisomerase II inhibitor |
112 | - | Nutlin-3 | Mdm2-p53 interaction inhibitor |
110 | M6545 | Mitoxantrone | DNA synthesis inhibitor |
108 | I1656 | Idarubicin | Antineoplastic |
104 | A9809 | Amsacrine | Topoisomerase II inhibitor |
91 | E1383 | Etoposide | Topoisomerase II inhibitor |
83 | T2705 | Topotecan | Topoisomerase I inhibitor |
82 | A8598 | Ancitabine hydrochloride | Antineoplastic |
80 | C6645 | Cytosine-1-ß-arabinofuranoside | DNA synthesis inhibitor |
78 | A6770 | Methotrexate hydrate | Folic acid antagonist |
76 | A1784 | Aminopterin | Dihydrofolate reductase inhibitor |
73 | G6423 | Gemcitabine | Antineoplastic |
64 | F6627 | 5-Fluorouracil | Thymidilate synthetase inhibitor |
63 | F8791 | 5-Fluoro-5’-deoxyuridine | DNA synthesis inhibitor |
59 | E3380 | Ellipticine | Topoisomerase II inhibitor |
58 | C9510 | Pyrocatechol | Carcinogen |